Jishnu Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.49 M
- Company Age 26 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.09 M
- Revenue Growth -27.10%
- Profit Growth -3.75%
- Ebitda 17.30%
- Net Worth 5.28%
- Total Assets 34.30%
About Jishnu Pharmaceuticals
Jishnu Pharmaceuticals Private Limited (JPPL) is a Private Limited Indian Non-Government Company incorporated in India on 23 October 1998 and has a history of 26 years and four months. Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.49 M.
The company currently has active open charges totaling ₹8.09 M.
Kamini Sachdeva and Harish Sachdeva serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24232DL1998PTC096784
- Company No.
096784
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Oct 1998
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Jishnu Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kamini Sachdeva  | Director | 23-Oct-1998 | Current |
| Harish Sachdeva | Director | 23-Oct-1998 | Current |
Financial Performance of Jishnu Pharmaceuticals.
Jishnu Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 27.1% decrease. The company also saw a slight decrease in profitability, with a 3.75% decrease in profit. The company's net worth moved up by a moderate rise of 5.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jishnu Pharmaceuticals?
In 2023, Jishnu Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Hemanya Healthcare Private LimitedHarish Sachdeva is a mutual person
Charges (Loans)
₹8.09 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.81 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Aug 2021 | Hdfc Bank Limited | ₹7.00 M | Open |
| 31 Oct 2020 | Hdfc Bank Limited | ₹1.09 M | Open |
How Many Employees Work at Jishnu Pharmaceuticals?
Unlock and access historical data on people associated with Jishnu Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jishnu Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jishnu Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.